Home » Topics » Disease categories and therapies » Urology

Urology
RSS

BBI Pharmaceuticals to fund phase I trial with soybean extract in BPH

March 14, 1997

Positive phase III results for GelTex's RenaGel

March 12, 1997

Roussel Uclaf reports agents for BPH

March 11, 1997

New selective alpha1a/A-antagonist from Abbott

March 10, 1997

Pharmacokinetic-pharmacodynamic interactions between terazosin and finasteride

March 3, 1997

Agents for urinary incontinence from Nippon Shinyaku

Feb. 28, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Agents for BPH disclosed by Merck & Co.

Feb. 19, 1997

Natural 5alpha-reductase inhibitors discovered at Taisho

Feb. 10, 1997

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...